Cevimeline hydrochloride, a remedy for treating xerostomia due to Sjögren's syndrome (referred to SS below), showed a superior effectiveness on this syndrome as compared with conventional remedies. However, some of the patients thus treated showed no or inadequate response. In the present study, therefore, possible background factors which may influence on the effect of this agent were examined.
One hundred patients so far diagnosed as SS in our department and treated with cevimeline hydrochloride for at least 12 months during the period from September 2001 to December 2003 were enrolled in this study. In these cases, possible background factors which may have influenced on the increase rates of salivary secretion, the amount of increase in saliva and the improvement rates of subjective symptoms were examined efficacy rate of after 12-month administration.
Both pre-administration gum test values and sequential salivary scintigraphy scores were found to have exerted influence on efficacy rate of the increase rates of the salivary secretion. And both pre-administration subjective symptom scores and sequential salivary scintigraphy scores were found to have exerted influence on efficacy rate of the amount of increase in saliva after 12-month administration. In addition, efficacy rate of the improvement rates of subjective symptoms seemed to have been influenced by the patient's age, presence or absence of collagen disease and pre-administration gum test values.
View full abstract